Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats

Pharmacological Research

Volumn 58, Issue 3-4, 2008, Pages 196-201

  Li, Ling ^a   Yi Ming, Wuliya ^b   Li, Zhen Zhen ^a   Zhao, Lei ^a   Yu, Yong Sheng ^a   Li, Dong Jie ^a   Xia, Chun Yan ^a   Liu, Jian Guo ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Cardiovascular hypertrophy; End organ damage; Hypertension; Inflammation; Renin angiotensin system

Indexed keywords

ANGIOTENSIN II; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; INFLAMMATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; GENE EXPRESSION; HEART RATE; INFLAMMATION MEDIATORS; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 54349106344     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.06.009     Document Type: Article

References (32)

1. Karpha M., and Lip G.V. The pathophysiology of target organ damage in hypertension. Minerva Cardioangiol 54 (2006) 417-429
2. Nadar S.K., Tayebjee M.H., Messerli F., and Lip G.Y. Target organ damage in hypertension: pathophysiology and implications for drug therapy. Curr Pharm Des 12 (2006) 1581-1592
3. Miao C.Y., Xie H.H., Zhan L.S., and Su D.F. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 24 (2006) 1125-1135
4. Schmieder R.E., Hilgers K.F., Schlaich M.P., and Schmidt B.M. Renin-angiotensin system and cardiovascular risk. Lancet 369 (2007) 1208-1219
5. Grandi A.M., and Maresca A.M. Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damage. Cardiovasc Hematol Agents Med Chem 4 (2006) 219-228
6. Li J.J., Fang C.H., and Hui R.T. Is hypertension an inflammatory disease?. Med Hypotheses 64 (2005) 236-240
7. Crowley S.D., Gurley S.B., Herrera M.J., Ruiz P., Griffiths R., Kumar A.P., et al. Angiotensin α causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 103 (2006) 17985-17990
8. Touyz R.M. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90 (2005) 449-455
9. Bader M. Role of the local renin-angiotensin system in cardiac damage: a mini-review focusing on transgenic animal models. J Mol Cell Cardiol 34 (2002) 1455-1462
10. Obata J., Nakamura T., Takano H., Naito A., Kimura H., Yoshida Y., et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 18 (2000) 1247-1255
11. Sironi L., Gelosa P., Guerrini U., Banfi C., Crippa V., Brioschi M., et al. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J Pharmacol Exp Ther 311 (2004) 989-995
12. Duprez D.A. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 24 (2006) 983-991
13. Jastrzebski M., Czarnecka D., Rajzer M., and Kawecka-Jaszcz K. Increased levels of inflammatory markers in hypertensives with target organ damage. Kardiol Pol 64 (2006) 802-811
14. Zhang C., Chen H., Xie H.H., Shu H., Yuan W.J., and Su D.F. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. J Hypertens 21 (2003) 2141-2148
15. Ma X.J., Shen F.M., Liu A.J., Shi K.Y., Wu Y.L., and Su D.F. Clonidine, moxonidine, folic acid, and mecobalamin improve baroreflex function in stroke-prone, spontaneously hypertensive rats. Acta Pharmacol Sin 28 (2007) 1550-1558
16. Shen F.M., Wang J., Ni C.R., Yu J.G., Wang W.Z., and Su D.F. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors. Clin Exp Pharmacol Physiol 34 (2007) 702-707
17. Zhang W., Liu A.J., Yi-Ming W., Liu J.G., Shen F.M., and Su D.F. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 35 (2008) 83-88
18. Wakahara S., Konoshita T., Mizuno S., Motomura M., Aoyama C., Makino Y., et al. Synergistic expression of ACE and ACE2 in human renal tissue and confounding effects of hypertension on the ACE/ACE2 ratio. Endocrinology 148 (2007) 2453-2457
19. Re N.E. The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol 16 (2001) 317-327
20. de Resende M.M., and Mill J.G. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. Clin Exp Pharmacol Physiol 34 (2007) 274-279
21. Paul M., Poyan Mehr A., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86 (2006) 747-803
22. Castoldi G., di Gioia C.R., Busca G., Redaelli S., Bombardi C., Kreutz R., et al. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect. Clin Exp Pharmacol Physiol 34 (2007) 205-209
23. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
24. Falcón B.L., Stewart J.M., Bourassa E., Katovich M.J., Walter G., Speth R.C., et al. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics 19 (2004) 255-261
25. Tomita N., Yamasaki K., Izawa K., Kunugiza Y., Osako M.K., Ogihara T., et al. Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats. Int J Mol Med 19 (2007) 571-579
26. Sun M., Chen M., Dawood F., Zurawska U., Li J.Y., Parker T., et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115 (2007) 1398-1407
27. Kurdi M., Randon J., Cerutti C., and Bricca G. Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats. Mol Cell Biochem 269 (2005) 95-101
28. Sasaki K., Taniguchi M., Miyoshi M., Goto O., Sato K., and Watanabe T. Are transcription factors NF-kappaB and AP-1 involved in the ANG II-stimulated production of proinflammatory factor induced by LPS in dehydrated rats?. Am J Physiol Regul Integr Comp Physiol 289 (2005) R1599-1608
29. Zhou J., Xu X., Liu J.J., Lin Y.X., and Gao G.D. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Clin Exp Pharmacol Physiol 34 (2007) 1191-1198
30. Higaki J., Aoki M., Morishita R., Kida I., Taniyama Y., Tomita N., et al. In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. Arterioscler Thromb Vasc Biol 20 (2000) 428-434
31. Liu A.J., Ma X.J., Shen F.M., Liu J.G., Chen H., and Su D.F. Arterial baroreflex: a novel target for preventing stroke in rat hypertension. Stroke 38 (2007) 1916-1923
32. Xie H.H., Miao C.Y., Jiang Y.Y., and Su D.F. Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats. J Hypertens 23 (2005) 193-201